Bringing together 60+ senior leaders from large pharma, innovative biotech, academia and investment companies, this conference will discuss data-driven and solution-based approaches that focus on developing high value clinical candidates, novel modalities and effective strategies, that address market sustainability and aim for superiority.
Each year, World Tuberculosis (TB) Day is commemorated on March 24 to raise public awareness about the devastating health, social and economic consequences of TB, and to step up efforts to end the global TB epidemic. The date marks the day in 1882 when Dr Robert Koch announced that he had discovered the bacterium that […]
This workshop provided an open discussion forum to identify, propose and prioritise specific challenges, success and risk factors in the development of vaccines against nosocomial AMR pathogens. Participants included experts in clinical vaccine development from industry, academia and regulatory agencies, as well as experts in innovative clinical trial designs. General discussion topics covered pre-existing clinical […]
